Improve Cancer-related Cognitive Impairment
Recruiting now · Not applicable
Conditions studied: Gynecologic Cancer, Chemotherapy Effect, Chemo-brain, Cancer-related Cognitive Difficulties
In brief
Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments. This application focuses on evaluating if using a cognitive mobile training application can decrease the impact of CRCI in gynecologic oncology patients through a multidisciplinary approach with patients undergoing assessments by our neurocognitive team.
Key facts
- Study ID
- NCT05864274
- Run by
- University of Alabama at Birmingham
- People needed
- 64
- Starts
- 2024-09-01
- Expected to finish
- 2027-08-01
- Last updated by the study team
- 2025-11-24
Who can join
Age: 18 and older, up to 90. Sex: female. Healthy volunteers: accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.